APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptic Ulcer Medication

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Peptic Ulcer Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchPeptic Ulcer Medication Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptic Ulcer Medication Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Peptic Ulcer Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptic Ulcer Medication Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptic Ulcer Medication Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Peptic Ulcer Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Peptic Ulcer Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptic Ulcer Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptic Ulcer Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Peptic Ulcer Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptic Ulcer Medication include AstraZeneca, Chongqing Lummy Pharmaceutical, CTTQ, Jumpcan Pharmaceutical, Livzon Pharmaceutical, Luoxin Pharmaceuticals, Youcare Pharmaceutical, Jiangsu Aosaikang Pharmaceutical and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Peptic Ulcer Medication market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptic Ulcer Medication and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptic Ulcer Medication revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Peptic Ulcer Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptic Ulcer Medication Segment by Company

AstraZeneca

Chongqing Lummy Pharmaceutical

CTTQ

Jumpcan Pharmaceutical

Livzon Pharmaceutical

Luoxin Pharmaceuticals

Youcare Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Teva Pharmaceuticals

Eisai

Takeda

Zhejiang Conba Pharmaceutical

Peptic Ulcer Medication Segment by Type

Proton Pump Inhibitors

Antacids

H2-Receptor Antagonists

Others

Peptic Ulcer Medication Segment by Application

Hospital and Clinic

Pharmacy

Peptic Ulcer Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptic Ulcer Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptic Ulcer Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptic Ulcer Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Peptic Ulcer Medication in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptic Ulcer Medication industry.

Chapter 3: Detailed analysis of Peptic Ulcer Medication companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptic Ulcer Medicationrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peptic Ulcer Medication Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Proton Pump Inhibitors Table 3. Key Players of Antacids Table 4. Key Players of H2-Receptor Antagonists Table 3. Key Players of Others Table 4. Global Peptic Ulcer Medication Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital and Clinic Table 6. Key Players of Pharmacy Table 7. Global Peptic Ulcer Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Peptic Ulcer Medication Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Peptic Ulcer Medication Market Share by Region (2021-2026) Table 10. Global Peptic Ulcer Medication Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Peptic Ulcer Medication Market Share by Region (2027-2032) Table 12. Peptic Ulcer Medication Industry Trends Table 13. Peptic Ulcer Medication Industry Drivers Table 14. Peptic Ulcer Medication Industry Opportunities and Challenges Table 15. Peptic Ulcer Medication Industry Restraints Table 16. Global Peptic Ulcer Medication Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Peptic Ulcer Medication Revenue Market Share by Company (2021-2026) Table 18. Global Peptic Ulcer Medication Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Peptic Ulcer Medication Key Company Head Office and Area Served Table 20. Global Peptic Ulcer Medication Company, Product Type & Application Table 21. Global Peptic Ulcer Medication Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Peptic Ulcer Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Peptic Ulcer Medication Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Peptic Ulcer Medication Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Peptic Ulcer Medication Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Peptic Ulcer Medication Revenue Market Share by Type (2021-2026) Table 28. Global Peptic Ulcer Medication Revenue Market Share by Type (2027-2032) Table 29. Global Peptic Ulcer Medication Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Peptic Ulcer Medication Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Peptic Ulcer Medication Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Peptic Ulcer Medication Revenue Market Share by Application (2021-2026) Table 33. Global Peptic Ulcer Medication Revenue Market Share by Application (2027-2032) Table 34. AstraZeneca Company Information Table 35. AstraZeneca Business Overview Table 36. AstraZeneca Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. AstraZeneca Peptic Ulcer Medication Product Portfolio Table 38. AstraZeneca Recent Development Table 39. Chongqing Lummy Pharmaceutical Company Information Table 40. Chongqing Lummy Pharmaceutical Business Overview Table 41. Chongqing Lummy Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Chongqing Lummy Pharmaceutical Peptic Ulcer Medication Product Portfolio Table 43. Chongqing Lummy Pharmaceutical Recent Development Table 44. CTTQ Company Information Table 45. CTTQ Business Overview Table 46. CTTQ Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. CTTQ Peptic Ulcer Medication Product Portfolio Table 48. CTTQ Recent Development Table 49. Jumpcan Pharmaceutical Company Information Table 50. Jumpcan Pharmaceutical Business Overview Table 51. Jumpcan Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Jumpcan Pharmaceutical Peptic Ulcer Medication Product Portfolio Table 53. Jumpcan Pharmaceutical Recent Development Table 54. Livzon Pharmaceutical Company Information Table 55. Livzon Pharmaceutical Business Overview Table 56. Livzon Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Livzon Pharmaceutical Peptic Ulcer Medication Product Portfolio Table 58. Livzon Pharmaceutical Recent Development Table 59. Luoxin Pharmaceuticals Company Information Table 60. Luoxin Pharmaceuticals Business Overview Table 61. Luoxin Pharmaceuticals Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Luoxin Pharmaceuticals Peptic Ulcer Medication Product Portfolio Table 63. Luoxin Pharmaceuticals Recent Development Table 64. Youcare Pharmaceutical Company Information Table 65. Youcare Pharmaceutical Business Overview Table 66. Youcare Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Youcare Pharmaceutical Peptic Ulcer Medication Product Portfolio Table 68. Youcare Pharmaceutical Recent Development Table 69. Jiangsu Aosaikang Pharmaceutical Company Information Table 70. Jiangsu Aosaikang Pharmaceutical Business Overview Table 71. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Medication Product Portfolio Table 73. Jiangsu Aosaikang Pharmaceutical Recent Development Table 74. Teva Pharmaceuticals Company Information Table 75. Teva Pharmaceuticals Business Overview Table 76. Teva Pharmaceuticals Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Teva Pharmaceuticals Peptic Ulcer Medication Product Portfolio Table 78. Teva Pharmaceuticals Recent Development Table 79. Eisai Company Information Table 80. Eisai Business Overview Table 81. Eisai Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Eisai Peptic Ulcer Medication Product Portfolio Table 83. Eisai Recent Development Table 84. Takeda Company Information Table 85. Takeda Business Overview Table 86. Takeda Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Takeda Peptic Ulcer Medication Product Portfolio Table 88. Takeda Recent Development Table 89. Zhejiang Conba Pharmaceutical Company Information Table 90. Zhejiang Conba Pharmaceutical Business Overview Table 91. Zhejiang Conba Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Zhejiang Conba Pharmaceutical Peptic Ulcer Medication Product Portfolio Table 93. Zhejiang Conba Pharmaceutical Recent Development Table 94. North America Peptic Ulcer Medication Market Size by Type (2021-2026) & (US$ Million) Table 95. North America Peptic Ulcer Medication Market Size by Type (2027-2032) & (US$ Million) Table 96. North America Peptic Ulcer Medication Market Size by Application (2021-2026) & (US$ Million) Table 97. North America Peptic Ulcer Medication Market Size by Application (2027-2032) & (US$ Million) Table 98. North America Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Peptic Ulcer Medication Market Size by Country (2021-2026) Table 100. North America Peptic Ulcer Medication Market Size by Country (2027-2032) Table 101. Europe Peptic Ulcer Medication Market Size by Type (2021-2026) & (US$ Million) Table 102. Europe Peptic Ulcer Medication Market Size by Type (2027-2032) & (US$ Million) Table 103. Europe Peptic Ulcer Medication Market Size by Application (2021-2026) & (US$ Million) Table 104. Europe Peptic Ulcer Medication Market Size by Application (2027-2032) & (US$ Million) Table 105. Europe Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Peptic Ulcer Medication Market Size by Country (2021-2026) Table 107. Europe Peptic Ulcer Medication Market Size by Country (2027-2032) Table 108. China Peptic Ulcer Medication Market Size by Type (2021-2026) & (US$ Million) Table 109. China Peptic Ulcer Medication Market Size by Type (2027-2032) & (US$ Million) Table 110. China Peptic Ulcer Medication Market Size by Application (2021-2026) & (US$ Million) Table 111. China Peptic Ulcer Medication Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Peptic Ulcer Medication Market Size by Type (2021-2026) & (US$ Million) Table 113. Asia Peptic Ulcer Medication Market Size by Type (2027-2032) & (US$ Million) Table 114. Asia Peptic Ulcer Medication Market Size by Application (2021-2026) & (US$ Million) Table 115. Asia Peptic Ulcer Medication Market Size by Application (2027-2032) & (US$ Million) Table 116. Asia Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Peptic Ulcer Medication Market Size by Country (2021-2026) Table 118. Asia Peptic Ulcer Medication Market Size by Country (2027-2032) Table 119. South America, Middle East & Africa Peptic Ulcer Medication Market Size by Type (2021-2026) & (US$ Million) Table 120. South America, Middle East & Africa Peptic Ulcer Medication Market Size by Type (2027-2032) & (US$ Million) Table 121. South America, Middle East & Africa Peptic Ulcer Medication Market Size by Application (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Peptic Ulcer Medication Market Size by Application (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. South America, Middle East & Africa Peptic Ulcer Medication Market Size by Country (2021-2026) Table 125. South America, Middle East & Africa Peptic Ulcer Medication Market Size by Country (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Peptic Ulcer Medication Product Image Figure 2. Global Peptic Ulcer Medication Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Peptic Ulcer Medication Market Share by Type: 2025 VS 2032 Figure 4. Proton Pump Inhibitors Image Figure 5. Antacids Image Figure 6. H2-Receptor Antagonists Image Figure 7. Others Image Figure 8. Global Peptic Ulcer Medication Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Peptic Ulcer Medication Market Share by Application: 2025 VS 2032 Figure 10. Hospital and Clinic Image Figure 11. Pharmacy Image Figure 12. Global Peptic Ulcer Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 14. Global Peptic Ulcer Medication Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Peptic Ulcer Medication Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Peptic Ulcer Medication Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Peptic Ulcer Medication Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Peptic Ulcer Medication Revenue Market Share by Type (2021-2032) Figure 21. Global Peptic Ulcer Medication Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Peptic Ulcer Medication Revenue Market Share by Application (2021-2032) Figure 23. North America Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 24. North America Peptic Ulcer Medication Market Share by Type (2021-2032) Figure 25. North America Peptic Ulcer Medication Market Share by Application (2021-2032) Figure 26. North America Peptic Ulcer Medication Market Share by Country (2021-2032) Figure 27. United States Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 28. Canada Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 30. Europe Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 31. Europe Peptic Ulcer Medication Market Share by Type (2021-2032) Figure 32. Europe Peptic Ulcer Medication Market Share by Application (2021-2032) Figure 33. Europe Peptic Ulcer Medication Market Share by Country (2021-2032) Figure 34. Germany Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 35. France Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 37. Italy Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 38. Russia Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 40. China Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 41. China Peptic Ulcer Medication Market Share by Type (2021-2032) Figure 42. China Peptic Ulcer Medication Market Share by Application (2021-2032) Figure 43. Asia Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 44. Asia Peptic Ulcer Medication Market Share by Type (2021-2032) Figure 45. Asia Peptic Ulcer Medication Market Share by Application (2021-2032) Figure 46. Asia Peptic Ulcer Medication Market Share by Country (2021-2032) Figure 47. Japan Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 51. India Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 52. Australia Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Peptic Ulcer Medication Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Peptic Ulcer Medication Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Peptic Ulcer Medication Market Share by Country (2021-2032) Figure 57. Brazil Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 62. UAE Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 64. Chile Peptic Ulcer Medication Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Proton Pump Inhibitors
  • Antacids
  • H2-Receptor Antagonists
  • Others
Applications
  • Hospital and Clinic
  • Pharmacy
Companies covered
  • AstraZeneca
  • Chongqing Lummy Pharmaceutical
  • CTTQ
  • Jumpcan Pharmaceutical
  • Livzon Pharmaceutical
  • Luoxin Pharmaceuticals
  • Youcare Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Teva Pharmaceuticals
  • Eisai
  • Takeda
  • Zhejiang Conba Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Peptic Ulcer Medication Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Proton Pump Inhibitors
  5. 1.2.3 Antacids
  6. 1.2.4 H2-Receptor Antagonists
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Peptic Ulcer Medication Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital and Clinic
  11. 1.3.3 Pharmacy
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Peptic Ulcer Medication Growth Trends by Region
  14. 1.5.1 Global Peptic Ulcer Medication Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Peptic Ulcer Medication Market Size by Region (2021-2026)
  16. 1.5.3 Peptic Ulcer Medication Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Peptic Ulcer Medication Market Dynamics
  1. 2.1 Peptic Ulcer Medication Industry Trends
  2. 2.2 Peptic Ulcer Medication Industry Drivers
  3. 2.3 Peptic Ulcer Medication Industry Opportunities and Challenges
  4. 2.4 Peptic Ulcer Medication Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Peptic Ulcer Medication Revenue by Company (2021-2026)
  2. 3.2 Global Peptic Ulcer Medication Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Peptic Ulcer Medication Key Company Head office and Area Served
  4. 3.4 Global Peptic Ulcer Medication Company, Product Type & Application
  5. 3.5 Global Peptic Ulcer Medication Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Peptic Ulcer Medication Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Peptic Ulcer Medication Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Peptic Ulcer Medication Tier 1, Tier 2, and Tier 3
4 Peptic Ulcer Medication Market by Type
  1. 4.1 Global Peptic Ulcer Medication Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Peptic Ulcer Medication Market Size by Type (2021-2032)
  3. 4.3 Global Peptic Ulcer Medication Market Size Share by Type (2021-2032)
5 Peptic Ulcer Medication Market by Application
  1. 5.1 Global Peptic Ulcer Medication Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Peptic Ulcer Medication Market Size by Application (2021-2032)
  3. 5.3 Global Peptic Ulcer Medication Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AstraZeneca Peptic Ulcer Medication Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Chongqing Lummy Pharmaceutical
  8. 6.2.1 Chongqing Lummy Pharmaceutical Company Information
  9. 6.2.2 Chongqing Lummy Pharmaceutical Business Overview
  10. 6.2.3 Chongqing Lummy Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Chongqing Lummy Pharmaceutical Peptic Ulcer Medication Product Portfolio
  12. 6.2.5 Chongqing Lummy Pharmaceutical Recent Developments
  13. 6.3 CTTQ
  14. 6.3.1 CTTQ Company Information
  15. 6.3.2 CTTQ Business Overview
  16. 6.3.3 CTTQ Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 CTTQ Peptic Ulcer Medication Product Portfolio
  18. 6.3.5 CTTQ Recent Developments
  19. 6.4 Jumpcan Pharmaceutical
  20. 6.4.1 Jumpcan Pharmaceutical Company Information
  21. 6.4.2 Jumpcan Pharmaceutical Business Overview
  22. 6.4.3 Jumpcan Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Jumpcan Pharmaceutical Peptic Ulcer Medication Product Portfolio
  24. 6.4.5 Jumpcan Pharmaceutical Recent Developments
  25. 6.5 Livzon Pharmaceutical
  26. 6.5.1 Livzon Pharmaceutical Company Information
  27. 6.5.2 Livzon Pharmaceutical Business Overview
  28. 6.5.3 Livzon Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Livzon Pharmaceutical Peptic Ulcer Medication Product Portfolio
  30. 6.5.5 Livzon Pharmaceutical Recent Developments
  31. 6.6 Luoxin Pharmaceuticals
  32. 6.6.1 Luoxin Pharmaceuticals Company Information
  33. 6.6.2 Luoxin Pharmaceuticals Business Overview
  34. 6.6.3 Luoxin Pharmaceuticals Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Luoxin Pharmaceuticals Peptic Ulcer Medication Product Portfolio
  36. 6.6.5 Luoxin Pharmaceuticals Recent Developments
  37. 6.7 Youcare Pharmaceutical
  38. 6.7.1 Youcare Pharmaceutical Company Information
  39. 6.7.2 Youcare Pharmaceutical Business Overview
  40. 6.7.3 Youcare Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Youcare Pharmaceutical Peptic Ulcer Medication Product Portfolio
  42. 6.7.5 Youcare Pharmaceutical Recent Developments
  43. 6.8 Jiangsu Aosaikang Pharmaceutical
  44. 6.8.1 Jiangsu Aosaikang Pharmaceutical Company Information
  45. 6.8.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  46. 6.8.3 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Medication Product Portfolio
  48. 6.8.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  49. 6.9 Teva Pharmaceuticals
  50. 6.9.1 Teva Pharmaceuticals Company Information
  51. 6.9.2 Teva Pharmaceuticals Business Overview
  52. 6.9.3 Teva Pharmaceuticals Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Teva Pharmaceuticals Peptic Ulcer Medication Product Portfolio
  54. 6.9.5 Teva Pharmaceuticals Recent Developments
  55. 6.10 Eisai
  56. 6.10.1 Eisai Company Information
  57. 6.10.2 Eisai Business Overview
  58. 6.10.3 Eisai Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Eisai Peptic Ulcer Medication Product Portfolio
  60. 6.10.5 Eisai Recent Developments
  61. 6.11 Takeda
  62. 6.11.1 Takeda Company Information
  63. 6.11.2 Takeda Business Overview
  64. 6.11.3 Takeda Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Takeda Peptic Ulcer Medication Product Portfolio
  66. 6.11.5 Takeda Recent Developments
  67. 6.12 Zhejiang Conba Pharmaceutical
  68. 6.12.1 Zhejiang Conba Pharmaceutical Company Information
  69. 6.12.2 Zhejiang Conba Pharmaceutical Business Overview
  70. 6.12.3 Zhejiang Conba Pharmaceutical Peptic Ulcer Medication Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Zhejiang Conba Pharmaceutical Peptic Ulcer Medication Product Portfolio
  72. 6.12.5 Zhejiang Conba Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Peptic Ulcer Medication Market Size (2021-2032)
  2. 7.2 North America Peptic Ulcer Medication Market Size by Type
  3. 7.2.1 North America Peptic Ulcer Medication Market Size by Type (2021-2026)
  4. 7.2.2 North America Peptic Ulcer Medication Market Size by Type (2027-2032)
  5. 7.2.3 North America Peptic Ulcer Medication Market Share by Type (2021-2032)
  6. 7.3 North America Peptic Ulcer Medication Market Size by Application
  7. 7.3.1 North America Peptic Ulcer Medication Market Size by Application (2021-2026)
  8. 7.3.2 North America Peptic Ulcer Medication Market Size by Application (2027-2032)
  9. 7.3.3 North America Peptic Ulcer Medication Market Share by Application (2021-2032)
  10. 7.4 North America Peptic Ulcer Medication Market Size by Country
  11. 7.4.1 North America Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Peptic Ulcer Medication Market Size by Country (2021-2026)
  13. 7.4.3 North America Peptic Ulcer Medication Market Size by Country (2027-2032)
  14. 7.4.4 North America Peptic Ulcer Medication Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Peptic Ulcer Medication Market Size (2021-2032)
  2. 8.2 Europe Peptic Ulcer Medication Market Size by Type
  3. 8.2.1 Europe Peptic Ulcer Medication Market Size by Type (2021-2026)
  4. 8.2.2 Europe Peptic Ulcer Medication Market Size by Type (2027-2032)
  5. 8.2.3 Europe Peptic Ulcer Medication Market Share by Type (2021-2032)
  6. 8.3 Europe Peptic Ulcer Medication Market Size by Application
  7. 8.3.1 Europe Peptic Ulcer Medication Market Size by Application (2021-2026)
  8. 8.3.2 Europe Peptic Ulcer Medication Market Size by Application (2027-2032)
  9. 8.3.3 Europe Peptic Ulcer Medication Market Share by Application (2021-2032)
  10. 8.4 Europe Peptic Ulcer Medication Market Size by Country
  11. 8.4.1 Europe Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Peptic Ulcer Medication Market Size by Country (2021-2026)
  13. 8.4.3 Europe Peptic Ulcer Medication Market Size by Country (2027-2032)
  14. 8.4.4 Europe Peptic Ulcer Medication Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Peptic Ulcer Medication Market Size (2021-2032)
  2. 9.2 China Peptic Ulcer Medication Market Size by Type
  3. 9.2.1 China Peptic Ulcer Medication Market Size by Type (2021-2026)
  4. 9.2.2 China Peptic Ulcer Medication Market Size by Type (2027-2032)
  5. 9.2.3 China Peptic Ulcer Medication Market Share by Type (2021-2032)
  6. 9.3 China Peptic Ulcer Medication Market Size by Application
  7. 9.3.1 China Peptic Ulcer Medication Market Size by Application (2021-2026)
  8. 9.3.2 China Peptic Ulcer Medication Market Size by Application (2027-2032)
  9. 9.3.3 China Peptic Ulcer Medication Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Peptic Ulcer Medication Market Size (2021-2032)
  2. 10.2 Asia Peptic Ulcer Medication Market Size by Type
  3. 10.2.1 Asia Peptic Ulcer Medication Market Size by Type (2021-2026)
  4. 10.2.2 Asia Peptic Ulcer Medication Market Size by Type (2027-2032)
  5. 10.2.3 Asia Peptic Ulcer Medication Market Share by Type (2021-2032)
  6. 10.3 Asia Peptic Ulcer Medication Market Size by Application
  7. 10.3.1 Asia Peptic Ulcer Medication Market Size by Application (2021-2026)
  8. 10.3.2 Asia Peptic Ulcer Medication Market Size by Application (2027-2032)
  9. 10.3.3 Asia Peptic Ulcer Medication Market Share by Application (2021-2032)
  10. 10.4 Asia Peptic Ulcer Medication Market Size by Country
  11. 10.4.1 Asia Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Peptic Ulcer Medication Market Size by Country (2021-2026)
  13. 10.4.3 Asia Peptic Ulcer Medication Market Size by Country (2027-2032)
  14. 10.4.4 Asia Peptic Ulcer Medication Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Peptic Ulcer Medication Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Peptic Ulcer Medication Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Peptic Ulcer Medication Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Peptic Ulcer Medication Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Peptic Ulcer Medication Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst